Cem Sievers
Impact in
- Cancer Research top 10%
- Aging top 10%
Papers in ⓘ
-
- Immunotherapy and Immune Responses 4
- Oncology 9
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 5
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Renato Paro (5 shared papers)Ritwick Sawarkar (2 shared papers)Clint Allen (11 shared papers)Maxwell Lee (2 shared papers)Shawn Gillespie (2 shared papers)Brian B. Liau (2 shared papers)Peter van Galen (2 shared papers)Laura K. Donohue (2 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (3 papers)Oral Oncology (2 papers)Nucleic Acids Research (2 papers)iScience (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Cem Sievers
19 papers receiving 983 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 192
- Aging 19
- Oncology 277
- Molecular Biology 653
- Immunology 197
Countries citing papers authored by Cem Sievers
This map shows the geographic impact of Cem Sievers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Sievers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Sievers more than expected).
Fields of papers citing papers by Cem Sievers
This network shows the impact of papers produced by Cem Sievers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Sievers. The network helps show where Cem Sievers may publish in the future.
Co-authors
The 25 scholars most cited alongside Cem Sievers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 354 | |
| 2 | 2012 | 114 | |
| 3 | 2020 | 97 | |
| 4 | 2015 | 78 | |
| 5 | 2012 | 68 | |
| 6 | 2013 | 52 | |
| 7 | 2021 | 34 | |
| 8 | 2023 | 32 | |
| 9 | 2016 | 30 | |
| 10 | 2018 | 30 | |
| 11 | 2015 | 22 | |
| 12 | 2021 | 17 | |
| 13 | 2023 | 15 | |
| 14 | 2021 | 13 | |
| 15 | 2014 | 12 | |
| 16 | 2022 | 10 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2024 | 4 | |
| 20 | 2023 | 0 |
About Cem Sievers
Cem Sievers is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Obstetrics and Gynecology, having authored 20 papers that have together received 994 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Epigenetics and DNA Methylation (4 papers), Immunotherapy and Immune Responses (4 papers), RNA modifications and cancer (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Genomics and Chromatin Dynamics (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (192 citations), Aging (19 citations), Oncology (277 citations), Molecular Biology (653 citations) and Immunology (197 citations). Cem Sievers has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Renato Paro, Ritwick Sawarkar, Clint Allen, Maxwell Lee, Shawn Gillespie, Brian B. Liau, Peter van Galen, Laura K. Donohue, Federico Comoglio and B Bernstein. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Oral Oncology, Nucleic Acids Research, iScience and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.